Spectral Medical Inc. (TSX: EDT) Stock Analysis & Fundamentals | ScreenerHero

Create free account

EDTSpectral Medical Inc.

TSX · CA · Healthcare · Diagnostics & Research · spectraldx.com

1.320CAD0.00%Mkt Cap: 282.06M $P/E: —1d ago

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activi…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

1M Perf

Higher

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap282.06M $

Enterprise Value296.89M $

Revenue (TTM)2.01M $

Gross Profit965.67K $

Net Income (TTM)-34.73M $

Revenue/Share0.0073 USD

Last Price1.320 CAD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees29

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)Infinity

PEG—

EV/EBITDA-38.23

EV/Revenue147.65

P/S140.28

P/B-5.48

EPS (TTM)-0.13

EPS (Forward)0.00

52W Range

0.770051% of range1.840

52W High1.840 CAD

52W Low0.7700 CAD

Profitability

Gross Margin54.30%

Oper. Margin-362.51%

EBITDA Margin0.00%

Profit Margin-1952.99%

ROE68.40%

ROA-781.84%

Growth

Revenue Growth55.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.94M $

CapEx (TTM)142.01K $

FCF Margin625.33%

FCF Yield4.46%

Net Debt14.82M $

Net Debt/EBITDA-1.91

Balance Sheet

Debt/Equity-0.31

Current Ratio0.06

Quick Ratio0.04

Book Value/Sh-0.2410 CAD

Cash/Share0.0070 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateDec 19, 2011

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)3.150 CAD

Upside (mean)+138.6%

Target Range2.800 CAD – 3.500 CAD

CAD2.800+138.6% to meanCAD3.500

# Analysts2

Ownership

Shares Out.293.42M

Float288.58M

Insiders17.08%

Institutions12.44%

Short Interest

Short Ratio5.5d

Short % Out.0.10%

Shares Short306.63K

Short (prev mo.)323.72K

Technical

SMA 501.383 (-4.6%)

SMA 2001.378 (-4.2%)

Beta0.23

S&P 52W Chg20.05%

Avg Vol (30d)54.47K

Avg Vol (10d)57.28K

Technical Indicators

RSI (14)36.2

MACD-0.0150

MACD Signal-0.0100

MACD Hist.-0.0050

BB Upper1.413 CAD

BB Middle1.367 CAD

BB Lower1.320 CAD

BB Width6.80%

ATR (14)0.0427 CAD

Vol Ratio (20d)0.77x